Invention Grant
- Patent Title: (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds
- Patent Title (中): （1-茚满酮） - （1,2,3,6-四氢吡啶）化合物
-
Application No.: US10940747Application Date: 2004-09-15
-
Publication No.: US07378425B2Publication Date: 2008-05-27
- Inventor: Yoichi Iimura , Takashi Kosasa , Yoshiharu Yamanishi
- Applicant: Yoichi Iimura , Takashi Kosasa , Yoshiharu Yamanishi
- Applicant Address: JP Bunkyo-ku
- Assignee: Eisai R & D Management Co., Ltd.
- Current Assignee: Eisai R & D Management Co., Ltd.
- Current Assignee Address: JP Bunkyo-ku
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP2002-095352 20020329
- Main IPC: C07D211/70
- IPC: C07D211/70 ; A61K31/44
Abstract:
The present invention provides an excellent sigma receptor binding agent and/or acetylcholinesterase inhibitor containing an (1-indanone)-(1,2,3,6-tetrahydropyridine) compound. More specifically, it provides an (1-indanone)-(1,2,3,6-tetrahydropyridine) compound represented by the following formula, a pharmacologically acceptable salt thereof or a hydrate thereof: In the formula (I), R1, R2, R3 and R4 are the same as or different from each other.
Public/Granted literature
- US20050124642A1 (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds Public/Granted day:2005-06-09
Information query
